Metal-Free CO Prodrugs Activated by Molecular Oxygen Protect against Doxorubicin-Induced Cardiomyopathy in Mice
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Xiaoxiao Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia 30303, United States. Hauptthemen laut MEDLINE: Prodrugs, Doxorubicin, Cardiomyopathies, Carbon Monoxide. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Carbon monoxide has been extensively studied for its various therapeutic activities in cell cultures and animal models. Great efforts have been made to develop noninhalational approaches for easy and controlled CO delivery. Herein, we introduce a novel metal-free CO prodrug approach that releases CO under near-physiological conditions. CO from the quinone-derived CO prodrugs is initiated by general acid/base-catalyzed tautomerization followed by oxidation by molecular oxygen to form the key norbornadienone intermediate, leading to cheletropic CO release only in an aerobic environment. Representative CO prodrug analog QCO-105 showed marked anti-inflammatory effects and HO-1 induction activity in RAW264.7 macrophages. In a mouse model of doxorubicin-induced cardiomyopathy, we show for the first time that the CO prodrug QCO-105 prevented cardiomyocyte injury, consistent with the known organ-protective effects of HO-1 and CO. Overall, such a new CO prodrug design serves as the starting point for developing CO-based therapy in attenuating the cardiotoxicity of doxorubicin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia 30303, United States.
- Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
ORCID-Profile: Xiaoxiao Yang, Gangli Wang, Binghe Wang
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Yang, X., Lu, W., Alves de Souza, R. W., Mao, Q., Baram, D., Tripathi, R., Wang, G., Otterbein, L. E., & Wang, B. (2024). Metal-Free CO Prodrugs Activated by Molecular Oxygen Protect against Doxorubicin-Induced Cardiomyopathy in Mice. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01431
Vancouver
Yang X, Lu W, Alves de Souza RW, Mao Q, Baram D, Tripathi R, et al. Metal-Free CO Prodrugs Activated by Molecular Oxygen Protect against Doxorubicin-Induced Cardiomyopathy in Mice. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01431
BibTeX
@article{Yang2024,
author = {Yang, Xiaoxiao and Lu, Wen and Alves de Souza, Rodrigo W and Mao, Qiyue and Baram, Dipak and Tripathi, Ravi and Wang, Gangli and Otterbein, Leo E and Wang, Binghe},
title = {Metal-Free CO Prodrugs Activated by Molecular Oxygen Protect against Doxorubicin-Induced Cardiomyopathy in Mice},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01431}
}
EUVIMED